Published in Arch Dermatol on December 01, 2007
Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J (2009) 3.93
The risk of stroke in patients with psoriasis. J Invest Dermatol (2009) 2.97
The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol (2008) 2.95
The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol (2010) 2.90
Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol (2011) 2.53
Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol (2010) 2.37
Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol (2010) 2.29
Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol (2008) 2.25
National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol (2008) 2.19
Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol (2011) 1.78
Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol (2013) 1.64
The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol (2011) 1.59
Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasis. Br J Dermatol (2009) 1.56
Diet and weight loss as a treatment for psoriasis. Arch Dermatol (2010) 1.38
Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol (2009) 1.38
Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis. Arch Dermatol (2012) 1.37
Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients. J Am Acad Dermatol (2011) 1.18
Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review. BMC Med Res Methodol (2011) 1.12
Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. Ann Rheum Dis (2012) 1.08
Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol (2009) 1.05
Progress in understanding the immunopathogenesis of psoriasis. Actas Dermosifiliogr (2009) 1.04
Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study. PLoS One (2011) 0.98
Psoriasis and hypertension severity: results from a case-control study. PLoS One (2011) 0.98
Is there truly a risk of lymphoma from biologic therapies? Dermatol Ther (2009) 0.96
Update on the natural history and systemic treatment of psoriasis. Adv Dermatol (2008) 0.96
Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature. J Gen Intern Med (2011) 0.95
Psoriasis and cardiovascular risk: strength in numbers. J Invest Dermatol (2010) 0.95
Is psoriasis a new cutaneous marker for metabolic syndrome? A study in Indian patients. Indian J Dermatol (2013) 0.87
Metabolic syndrome in patients with psoriatic disease. J Rheumatol Suppl (2012) 0.87
Association between psoriasis and incident cancer: the Iowa's Women's Health Study. Cancer Causes Control (2011) 0.87
The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities. F1000 Med Rep (2009) 0.86
Cardiovascular comorbiditiy in psoriasis. Indian J Dermatol (2011) 0.83
Differing effect of systemic anti psoriasis therapies on platelet physiology--a case report and review of literature. BMC Dermatol (2010) 0.82
Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature. Biologics (2009) 0.79
Perspective: Don't be superficial. Nature (2012) 0.79
Assessing long-term drug safety: lessons (re) learned from raptiva. Semin Cutan Med Surg (2010) 0.79
Non-alcoholic fatty liver disease and psoriasis: So far, so near. World J Hepatol (2015) 0.79
Psoriasis and Cardiovascular Risk: Assessment by CUORE Project Risk Score in Italian Patients. Dermatol Res Pract (2013) 0.78
Potential role of ustekinumab in the treatment of chronic plaque psoriasis. Biologics (2010) 0.78
Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis. Arthritis Care Res (Hoboken) (2015) 0.78
Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature. Patient Prefer Adherence (2016) 0.78
Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial. Trials (2016) 0.77
Psoriasis: classical and emerging comorbidities. An Bras Dermatol (2015) 0.77
Systemic role for vitamin d in the treatment of psoriasis and metabolic syndrome. Dermatol Res Pract (2011) 0.76
Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences. Br J Dermatol (2014) 0.76
Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician. Can Fam Physician (2012) 0.75
Visualization of atherosclerosis as detected by coronary artery calcium and carotid intima-media thickness reveals significant atherosclerosis in a cross-sectional study of psoriasis patients in a tertiary care center. J Transl Med (2016) 0.75
Long-term use of adalimumab in the treatment of moderate to severe plaque psoriasis: a review of the literature. Clin Cosmet Investig Dermatol (2010) 0.75
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study. An Bras Dermatol (2017) 0.75
The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives. Am Health Drug Benefits (2016) 0.75
Diabetes mellitus and the skin. An Bras Dermatol (2017) 0.75
Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian Perspective. Dermatol Ther (Heidelb) (2016) 0.75
Genetic screening test for psoriatic arthritis and UVB irradiation potential responders: A new tool to identify psoriasis subpopulation patients? Indian Dermatol Online J (2011) 0.75
Treatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort study. BMC Dermatol (2013) 0.75
Treatment costs of psoriasis in a tertiary-level clinic. BMC Health Serv Res (2014) 0.75
Cardiovascular risk evaluation through heart rate variability analysis in psoriatic patients before and after 24 weeks of etanercept therapy: Prospective study. J Int Med Res (2016) 0.75
Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol (2017) 0.75
Psoriasis as a human model of disease to study inflammatory atherogenesis. Am J Physiol Heart Circ Physiol (2017) 0.75
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Role of computerized physician order entry systems in facilitating medication errors. JAMA (2005) 26.32
Linking long-term dietary patterns with gut microbial enterotypes. Science (2011) 17.30
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA (2006) 9.53
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med (2013) 9.44
Risk of myocardial infarction in patients with psoriasis. JAMA (2006) 9.42
Financial incentive-based approaches for weight loss: a randomized trial. JAMA (2008) 7.01
A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med (2009) 6.08
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf (2007) 5.93
Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care (2011) 5.63
Phase II trial of sorafenib in advanced thyroid cancer. J Clin Oncol (2008) 5.31
Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med (2003) 5.09
The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology (2002) 4.98
Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags. BMC Microbiol (2010) 4.97
Oral contraceptives and the risk of breast cancer. N Engl J Med (2002) 4.85
Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol (2003) 4.27
Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol (2006) 4.12
Design of a national distributed health data network. Ann Intern Med (2009) 4.09
Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J (2009) 3.93
Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA (2011) 3.58
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology (2004) 3.57
Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol (2004) 3.43
Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc (2004) 3.40
The human gut virome: inter-individual variation and dynamic response to diet. Genome Res (2011) 3.32
Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation (2005) 3.28
The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf (2005) 3.24
Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ (2013) 3.22
Statin use and the risk of 10 cancers. Epidemiology (2007) 3.17
Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol (2005) 3.11
Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res (2006) 3.06
Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage (2003) 3.05
Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol (2005) 3.04
Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. Am J Gastroenterol (2002) 3.01
The risk of stroke in patients with psoriasis. J Invest Dermatol (2009) 2.97
The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol (2010) 2.90
The FDA and drug safety: a proposal for sweeping changes. Arch Intern Med (2006) 2.74
Mortality associated with medical therapy versus elective colectomy in ulcerative colitis: a cohort study. Ann Intern Med (2014) 2.73
Individual- versus group-based financial incentives for weight loss: a randomized, controlled trial. Ann Intern Med (2013) 2.59
Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy. AIDS (2006) 2.57
Rapid evolution of the human gut virome. Proc Natl Acad Sci U S A (2013) 2.53
Retrospective drug utilization review, prescribing errors, and clinical outcomes. JAMA (2003) 2.51
Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA (2012) 2.51
Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ (2002) 2.46
Use of abdominopelvic computed tomography in emergency departments and rates of urgent diagnoses in Crohn's disease. Clin Gastroenterol Hepatol (2011) 2.40
Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol (2002) 2.39
Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol (2011) 2.36
Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study. Cancer Causes Control (2008) 2.35
Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction. Ann Intern Med (2005) 2.34
Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology (2012) 2.26
A test of financial incentives to improve warfarin adherence. BMC Health Serv Res (2008) 2.23
Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results. Inflamm Bowel Dis (2012) 2.23
Antibiotics, acne, and Staphylococcus aureus colonization. Arch Dermatol (2011) 2.22
The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol (2002) 2.21
Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression. J Clin Epidemiol (2007) 2.19
Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials. Circulation (2012) 2.19
Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting. Arch Dermatol (2012) 2.19
The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus. Arch Dermatol (2008) 2.17
Managed problem solving for antiretroviral therapy adherence: a randomized trial. JAMA Intern Med (2013) 2.16
Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2006) 2.16
Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology (2005) 2.15
Statin use and the risk of breast and prostate cancer. Epidemiology (2002) 2.15
Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum (2012) 2.15
Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. Gastroenterology (2006) 2.14
Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study. Am J Ophthalmol (2012) 2.14
Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf (2002) 2.12
White paper on CTSA consortium role in facilitating comparative effectiveness research: September 23, 2009 CTSA consortium strategic goal committee on comparative effectiveness research. Clin Transl Sci (2010) 2.09
AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology (2010) 2.09
Financial incentives for extended weight loss: a randomized, controlled trial. J Gen Intern Med (2011) 2.07
An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index. Inflamm Bowel Dis (2014) 2.05
Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy. Arthritis Care Res (Hoboken) (2015) 2.03
Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Carcinogenesis (2008) 2.03
Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer. J Clin Oncol (2008) 2.02
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01
An index of local sensitivity to nonignorable drop-out in longitudinal modelling. Stat Med (2005) 2.00
Framing Financial Incentives to Increase Physical Activity Among Overweight and Obese Adults: A Randomized, Controlled Trial. Ann Intern Med (2016) 1.96
Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol (2003) 1.95
Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology (2003) 1.94